Stock Scorer

Guided Therapeutics Inc (GTHP) · Insider trading

What Guided Therapeutics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
$0
bought less sold
Latest filing
2026-05-05
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-03: $167,601 bought 2025-07 2025-08: $35,000 bought 2026-01 2026-07
Bought Sold Largest month: $167,601

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Imhoff John EDirector, 10% owner $156,307 – 6 2025-08-29 19,463,495
James Michael CDirector $46,295 – 3 2025-08-29 553,495
Grujic AlanDirector – – 1 2025-08-29 1,817,541

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2025-08-29 James Michael CDirector Buy 27,778 0.18 $5,000 553,495 Form 4
2025-08-29 Imhoff John EDirector, 10% owner Buy 166,667 0.18 $30,000 19,463,495 Form 4
2025-08-29 Grujic AlanDirector Buy 152,108 – – 1,817,541 Form 4
2025-03-18 Imhoff John EDirector, 10% owner Buy 1,000,000 0.10 $100,000 17,722,946 Form 4/A
2025-03-18 Imhoff John EDirector, 10% owner Buy 263,069 0.10 $26,307 17,986,015 Form 4/A
2025-03-18 James Michael CDirector Buy 150,000 0.10 $15,000 262,772 Form 4
2025-03-18 James Michael CDirector Buy 262,945 0.10 $26,294 525,717 Form 4
2025-03-13 Imhoff John EDirector, 10% owner Buy 150 – – 400 Form 4/A
2025-03-07 Imhoff John EDirector, 10% owner Buy 286 – – 286 Form 4/A
2024-12-18 Imhoff John EDirector, 10% owner Buy 1,615,385 – – 8,727,444 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

31 × other4 × conversion2 × option exercise1 × option exercise
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-03-31 Imhoff John EDirector, 10% owner Conversion C +157,417 0.07 21,252,673 Form 4
2026-03-26 Blumberg Richard P.Director, 10% owner Other J +56,093 – 8,980,273 Form 4
2026-03-26 Blumberg Richard P.Director, 10% owner Other J −260 – 0 Form 4
2026-03-26 Blumberg Richard P.Director, 10% owner Other J +1,040,000 – 10,020,273 Form 4
2026-03-26 Blumberg Richard P.Director, 10% owner Other J +19,038 – 10,039,311 Form 4
2026-03-26 Blumberg Richard P.Director, 10% owner Other J −88 – 0 Form 4
2026-03-26 Blumberg Richard P.Director, 10% owner Other J +352,000 – 10,391,311 Form 4
2026-03-26 Imhoff John EDirector, 10% owner Other J +2,157 – 21,055,256 Form 4
2026-03-26 Imhoff John EDirector, 10% owner Other J −10 – 0 Form 4
2026-03-26 Imhoff John EDirector, 10% owner Other J +40,000 – 21,095,256 Form 4
2026-02-27 Imhoff John EDirector, 10% owner Other J −100 – 0 Form 4
2026-02-27 Imhoff John EDirector, 10% owner Other J +400,000 – 20,897,013 Form 4
2026-02-27 Imhoff John EDirector, 10% owner Conversion C +156,086 0.07 21,053,099 Form 4
2026-02-25 Blumberg Richard P.Director, 10% owner Option exercise M +1,000,000 – 8,924,180 Form 4
2026-02-25 Imhoff John EDirector, 10% owner Option exercise X +500,000 – 20,497,013 Form 4
2026-02-25 James Michael CDirector Option exercise X +100,000 – 653,495 Form 4
2026-02-02 Imhoff John EDirector, 10% owner Conversion C +312,720 0.07 19,997,013 Form 4
2026-01-05 Imhoff John EDirector, 10% owner Other J +25,338 – 19,684,293 Form 4
2025-12-18 Imhoff John EDirector, 10% owner Conversion C +195,460 0.07 19,658,955 Form 4
2025-08-21 Blumberg Richard P.Director, 10% owner Other J +81,121 – 6,992,180 Form 4
2025-08-21 Blumberg Richard P.Director, 10% owner Other J −233 – 0 Form 4
2025-08-21 Blumberg Richard P.Director, 10% owner Other J +932,000 – 7,924,180 Form 4
2025-08-21 Imhoff John EDirector, 10% owner Other J +104,448 – 18,096,828 Form 4
2025-08-21 Imhoff John EDirector, 10% owner Other J −300 – 100 Form 4
2025-08-21 Imhoff John EDirector, 10% owner Other J +1,200,000 – 19,296,828 Form 4
2025-08-21 Grujic AlanDirector Other J +17,408 – 1,465,433 Form 4
2025-08-21 Grujic AlanDirector Other J −50 – 0 Form 4
2025-08-21 Grujic AlanDirector Other J +200,000 – 1,665,433 Form 4
2025-04-10 Blumberg Richard P.Director, 10% owner Other J +165,481 – 6,855,206 Form 4
2025-04-10 Blumberg Richard P.Director, 10% owner Other J +55,853 – 6,911,059 Form 4
2025-04-10 Imhoff John EDirector, 10% owner Other J +6,365 – 17,992,380 Form 4/A
2025-03-11 Imhoff John EDirector, 10% owner Other J −286 – 0 Form 4/A
2025-03-11 Imhoff John EDirector, 10% owner Other J +2,258,690 0.13 16,722,946 Form 4/A
2025-03-06 Imhoff John EDirector, 10% owner Other J −300 – 0 Form 4/A
2025-03-06 Imhoff John EDirector, 10% owner Other J +900,000 – 9,662,756 Form 4/A
2025-03-06 Imhoff John EDirector, 10% owner Other J −2,401 – 0 Form 4/A
2025-03-06 Imhoff John EDirector, 10% owner Other J +4,801,500 0.50 14,464,256 Form 4/A
2025-01-17 Imhoff John E10% owner Other J +35,312 – 8,762,756 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Guided Therapeutics's scores and multiples ›